3 reasons why I think the InvoCare Limited share price is a long-term buy

The InvoCare Limited (ASX:IVC) share price could be a strong long-term buy at today's price.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price has been a great performer over the last five years, growing by 89%. InvoCare is the largest operator of funerals and cemeteries in Australia.

I think there could be a lot more growth to come from InvoCare for the following reasons:

Defensive earnings

You know you have a defensive business when Benjamin Franklin made a famous quote about your industry.

The only things certain in life: death and taxes.

The sad reality is that a certain number of Australians do die every year and their families will probably want to hold a special funeral for them. This is a sizeable amount of almost guaranteed earnings with InvoCare having around a third of the market.

Growing industry

The death rate of Australia is expected to increase every year until 2034. This is due to Australians living longer and the ageing demographics.

This is a very strong tailwind for InvoCare to have and should provide ample opportunity for management to grow the business.

In the annual report to 31 December 2016 the business grew its revenue by 3.3% and its operating earnings per share by 11.8%. As the death rate quickens I imagine its earnings will grow at a faster rate too.

Strong dividend growth

The consistent growth of profit achieved by InvoCare has seen its dividend increase every year since 2006.

InvoCare is currently trading with a grossed-up dividend yield of 4.12% and increased its half-year dividend by 11.8% in its latest report.

Foolish takeaway

InvoCare could claim to be the most defensive business on the ASX. It's currently trading at 28x FY17's estimated earnings, this isn't cheap but I'm not sure the stock will ever be truly cheap with the tailwinds it has.

I would be a long-term buyer at today's prices, although hopefully I can buy more shares at a cheaper price in the future.

Motley Fool contributor Tristan Harrison owns shares of InvoCare Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »